| Profile for slimenimamunin |
|---|
|
SignatureTreatment of heart failure (NYHA class II-IV); Diovan significantly reduced hospitalization for heart failure ( 1.2). Reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction ( 1.3).... |
